Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2/3 1Phase 2 1Phase 1/2 1

Status

Completed 2Withdrawn 1Recruiting 1

Sponsor Class

OTHER 2OTHER_GOV 1NIH 1

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Lymphoid 3Other hematologic neoplasm 2Myeloid 1

Conditions

Breast Neoplasms 10184Neoplasms 7810Carcinoma, Non-Small-Cell Lung 5760Prostatic Neoplasms 5024Colorectal Neoplasms 4606Lung Neoplasms 3725Leukemia, Myeloid, Acute 3102Neoplasm Metastasis 3083Multiple Myeloma 3082Pancreatic Neoplasms 2845Melanoma 2653Ovarian Neoplasms 2573Lymphoma 2571Carcinoma, Hepatocellular 2480Stomach Neoplasms 2330Recurrence 2230Head and Neck Neoplasms 2103Precursor Cell Lymphoblastic Leukemia-Lymphoma 2086Lymphoma, Non-Hodgkin 2058Leukemia 2013Brain Neoplasms 1905Glioblastoma 1797Colonic Neoplasms 1791Leukemia, Lymphocytic, Chronic, B-Cell 1771Rectal Neoplasms 1720Uterine Cervical Neoplasms 1693Squamous Cell Carcinoma of Head and Neck 1654Lymphoma, Follicular 1652Lymphoma, Large B-Cell, Diffuse 1597Carcinoma, Renal Cell 1577

Interventions

dolutegravir 1Ritonavir 1Nucleosides 1Darunavir 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Opportunistic Infections × Clear all
NCT03922724 2026-06-05

Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma

National Institutes of Health Clinical Center (CC)

Phase 2 Recruiting
330 enrolled
Lymphoid

Autoimmune Diseases, Immune System Diseases, Lymphoproliferative Disorders, Opportunistic Infections, Lymphoma, T-Cell, Peripheral

NCT02942173 2023-03-16

CD45RA Depleted T-cell Infusion for Prevention of Infections After TCRab/CD19-depleted Allo-HSCT

Federal Research Institute of Pediatric Hematology, Oncology and Immunology

Phase 2/3 Completed
150 enrolled
LymphoidMyeloidOther hematologic neoplasm

Graft vs Host Disease, Leukemia, Lymphoma, Myelodysplastic Syndromes, Opportunistic Infections

NCT04183738 2020-11-10

i2-D²EFT

Kirby Institute

Phase 4 Withdrawn

Acquired Immunodeficiency Syndrome, Cytomegalovirus Infections, Inflammation, Opportunistic Infections, Epstein-Barr Virus Infections, Coinfection

NCT02337595 2016-04-22

45RA_NEG_DLI

Federal Research Institute of Pediatric Hematology, Oncology and Immunology

Phase 1/2 Completed
30 enrolled
LymphoidOther hematologic neoplasm

Immune Deficiency Disease, Bone Marrow Failure Disorders, Graft vs Host Disease, Opportunistic Infections, Leukemia, Myeloid, Acute, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡